1. Home
  2. IMNM vs ITRN Comparison

IMNM vs ITRN Comparison

Compare IMNM & ITRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • ITRN
  • Stock Information
  • Founded
  • IMNM 2006
  • ITRN 1994
  • Country
  • IMNM United States
  • ITRN Israel
  • Employees
  • IMNM N/A
  • ITRN N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • ITRN Electronic Components
  • Sector
  • IMNM Health Care
  • ITRN Technology
  • Exchange
  • IMNM Nasdaq
  • ITRN Nasdaq
  • Market Cap
  • IMNM 945.8M
  • ITRN 810.3M
  • IPO Year
  • IMNM 2020
  • ITRN 2005
  • Fundamental
  • Price
  • IMNM $9.01
  • ITRN $35.63
  • Analyst Decision
  • IMNM Strong Buy
  • ITRN Buy
  • Analyst Count
  • IMNM 8
  • ITRN 1
  • Target Price
  • IMNM $24.75
  • ITRN $50.00
  • AVG Volume (30 Days)
  • IMNM 1.0M
  • ITRN 174.4K
  • Earning Date
  • IMNM 11-12-2025
  • ITRN 08-19-2025
  • Dividend Yield
  • IMNM N/A
  • ITRN 5.63%
  • EPS Growth
  • IMNM N/A
  • ITRN 9.57
  • EPS
  • IMNM N/A
  • ITRN 2.79
  • Revenue
  • IMNM $12,589,000.00
  • ITRN $339,610,000.00
  • Revenue This Year
  • IMNM N/A
  • ITRN $7.03
  • Revenue Next Year
  • IMNM $154.73
  • ITRN $9.69
  • P/E Ratio
  • IMNM N/A
  • ITRN $12.96
  • Revenue Growth
  • IMNM 16.74
  • ITRN 3.30
  • 52 Week Low
  • IMNM $5.15
  • ITRN $25.87
  • 52 Week High
  • IMNM $16.73
  • ITRN $45.43
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 43.25
  • ITRN 47.12
  • Support Level
  • IMNM $9.01
  • ITRN $32.71
  • Resistance Level
  • IMNM $9.63
  • ITRN $36.19
  • Average True Range (ATR)
  • IMNM 0.71
  • ITRN 1.23
  • MACD
  • IMNM -0.07
  • ITRN 0.29
  • Stochastic Oscillator
  • IMNM 17.38
  • ITRN 80.44

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About ITRN Ituran Location and Control Ltd.

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services and Telematics products. The Telematics services segment consists of regionally-based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others. The company derives maximum revenue from Israel.

Share on Social Networks: